Displaying all 2 publications

Abstract:
Sort:
  1. Fulltext Taking action through stories: Promoting carbon-neutral meat consumption with narrative and message framing
    Duong C, Sung B, Wang X, Chong AWC
    Appetite, 2025 Mar 01;207:107895.
    PMID: 39938749 DOI: 10.1016/j.appet.2025.107895
    Carbon-neutral meat products offer a unique opportunity to reduce anthropogenic emissions. Supporting the growth of carbon-neutral meat is carbon labelling, an initiative to encourage environmentally friendly behaviour via information transparency. However, the efficacy of carbon labels remains questionable because consumers mainly cannot comprehend and connect with the labels. This raises a question of how communication could be leveraged to bridge that information asymmetry. Through five online controlled experiments, the study demonstrates the usefulness of narrative storytelling and message framing in heightening the effectiveness of carbon labels. Using realistic meat packaging designs with high ecological validity, the results show that even a simple and short-form narrative could be effective in enhancing the efficacy of carbon labels. Follow-up studies repeatedly demonstrate that the positive effect of narrative is accentuated by pairing with a gain-framed message. The effect of such a pairing was underpinned by a heightened feeling of certainty regarding the carbon-neutral meat's environmental impact message comprehension. The findings present a simple but often-forgotten notion that consumers seek optimal decisions with minimal cognitive effort. Hence, when given an alternative that is less cognitively demanding (to decode a message), consumers often prefer such a choice as it was reflected by a favourable attitude and heightened intent to purchase.
  2. Asia Pacific Gastroesophageal Cancer Congress (APGCC) 2024 consensus statement on stage 2 and 3 locally advanced gastric and Siewert 3 junctional adenocarcinoma
    Masuda Y, Fong KL, Yeo D, Yeo C, Chue KM, Araba SB, et al.
    J Gastroenterol, 2025 Sep;60(9):1079-1090.
    PMID: 40514519 DOI: 10.1007/s00535-025-02266-4
    BACKGROUND: While the development in multimodal therapies has helped improve treatment outcomes for patients with locally advanced gastric adenocarcinoma (LAGC), there still exist disparities in opinion with an optimal treatment plan. This consensus hopes to provide clinicians with structured guidelines to aid in the decision-making for treatment options for LAGC.

    METHODS: The consensus statement was initiated by establishing a taskforce in collaboration with the Asia Pacific Gastroesophageal Cancer Congress (APGCC) and a multidisciplinary expert panel was selected. Clinical questions on LAGC where perceived variance in practice or opinion may exist were formulated. Studies involving patients with Stage 2 or 3 gastric or Siewert 3 junctional cancers with treatment arms of perioperative chemotherapy, neoadjuvant chemotherapy, adjuvant chemotherapy, immunotherapy and surgery were included. A total of two rounds of voting were performed. Consensus was determined to be reached when a single answer or a combination of either "strongly agree/agree" or "strongly disagree/disagree" responses exceeded 75%.

    RESULTS: A total of thirteen clinical questions were developed. They were identified through five main categories: Distal LAGC, Proximal LAGC, Deficient mismatch repair tumors, Chemotherapy and Immunotherapy, and Elderly/Unfit patients. After two rounds of voting by our multidisciplinary expert panel, eleven out of a total thirteen clinical questions had reached consensus. No consensus was reached for two clinical questions.

    CONCLUSION: The APGCC consensus statement aims to guide clinicians in the treatment options for LAGC and Siewert 3 junctional cancer and has clarified some of the roles of perioperative chemotherapy and immunotherapy.

Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links